{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"2","upperLimit":"17","value":"9"},{"groupId":"OG001","lowerLimit":"2","upperLimit":"30","value":"16"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"54"},{"groupId":"OG001","value":"25"}],"units":"Participants"}],"description":"Local relapse is any evidence of new disease within the primary tumor bed or the regional (retroperitoneal, celiac, and portal vein nodes) lymphatics (these areas are to be encompassed within the radiation fields).","dispersionType":"95% Confidence Interval","groups":[{"description":"Eligible and analyzable patients that received a resection with negative (R0) margins.","id":"OG000","title":"Patients With Negative Margins of Resection (R0)"},{"description":"Eligible and analyzable patients that received a resection with microscopically positive (R1) margins.","id":"OG001","title":"Patients w/Microscopically Positive Margin of Resection (R1)"}],"paramType":"NUMBER","populationDescription":"Eligible and analyzable patients that received protocol treatment.","reportingStatus":"POSTED","timeFrame":"Up to 2 years from registration","title":"2-year Stratum-specific Local Relapse Rate","type":"SECONDARY","unitOfMeasure":"percentage of participants"}